Expertise

Shraddha Bhange, MD, MBBS, Msc.

Associate Medical Director, Pharmacovigilance

EVERSANA

Shraddha Bhange, MD, MBBS, Msc.

Dr. Bhange is a trained physician with years of clinical/medical practice experience and has nearly one decade of experience in pharmacovigilance, regulatory inspections, project management and client onboarding experience. She has worked in various therapeutic areas such as vaccine, oncology, diabetics, neurology, and generics. She has worked on postmarking and phase I to phase III drugs and supported product approvals in US, Europe and India. Her focus continues to be on safety with a demonstrated track record of working successfully to support numerous clients in ensuring safety of their products by adhering to compliance requirement and patient requirements. Shraddha is skilled in various regulatory/health agency regulations, especially USFDA, EMA, MHRA, and DCGI.  Her other areas of interest are medical communications, quality assurance, performance metrics and KPIs.

Dr. Bhange earned her Bachelor of Medicine and Bachelor of Surgery (MBB) from the Maharashtra University of Health Sciences (MUHS) under the Medical Council of India (MCI), and completed a specialized postgraduate full time program in paraclinical subjects, Msc Biomed tech from Coventry University, United Kingdom.

Expertise:

Compliance, Medical Information, Medical Information & Pharmacovigilance, Pharmacovigilance, Regulatory, Regulatory Compliance, Safety Surveillance

Articles by Shraddha Bhange, MD, MBBS, Msc.

COVID-19 Vaccine Safety Briefing Report

As the world awaits the fast-approaching rollout of an approved COVID-19 vaccine, developing the planning to order, distribute and track COVID-19 vaccines in the United States and globally presents an unprecedented challenge. The Food and Drug Administration (FDA) released a detailed analysis that concluded that the Pfizer and BioNTech COVID-19 vaccine is effective and safe, […]

Interested in scheduling a meeting or speaking event?

Contact Us

  • This field is for validation purposes and should be left unchanged.